Michel H Maillard
Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
Perrig K, Krupka N, Jordi S, Rossel J, Biedermann L, Greuter T, Schreiner P, Vavricka S, Juillerat P, Burri E, Zimmermann D, Maillard M, Sulz M, Brand S, Rogler G, Misselwitz B. Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland. Therap Adv Gastroenterol 2022; 15:17562848221074188.
09.02.2022Effectiveness of golimumab in patients with ulcerative colitis: results of a real-life study in Switzerland.
09.02.2022Therap Adv Gastroenterol 2022; 15:17562848221074188
Perrig Kathrin, Krupka Niklas, Jordi Sebastian Bruno Ulrich, Rossel Jean-Benoit, Biedermann Luc, Greuter Thomas, Schreiner Philipp, Vavricka Stephan R, Juillerat Pascal, Burri Emanuel, Zimmermann Dorothee, Maillard Michel H, Sulz Michael Christian, Brand Stephan, Rogler Gerhard, Misselwitz Benjamin
Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
Schreiner P, Rogler G, Juillerat P, Vavricka S, Vulliemoz M, Restellini S, Schoepfer A, Michetti P, Brand S, Maillard M, Fehr J, Mueller N, Biedermann L. Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know. J Crohns Colitis 2020
27.06.2020Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know
27.06.2020J Crohns Colitis 2020
Schreiner Philipp, Rogler Gerhard, Juillerat Pascal, Vavricka Stephan R, Vulliemoz Marianne, Restellini Sophie, Schoepfer Alain, Michetti Pierre, Brand Stephan, Maillard Michel H, Fehr Jan, Mueller Nicolas J, Biedermann Luc
Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
Yilmaz B, Stelling J, Wiest R, Swiss IBD Cohort Investigators, Rogler G, Maillard M, Pittet V, Geuking M, Mueller C, Michetti P, Fournier N, Franc Y, Bravo F, Ramon C, Øyås O, Juillerat P, Macpherson A. Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease. Nat Med 2019; 25:701.
01.04.2019Publisher Correction: Microbial network disturbances in relapsing refractory Crohn's disease
01.04.2019Nat Med 2019; 25:701
Yilmaz Bahtiyar, Stelling Jörg, Wiest Reiner, Swiss IBD Cohort Investigators, Rogler Gerhard, Maillard Michel H, Pittet Valerie E H, Geuking Markus, Mueller Christoph, Michetti Pierre, Fournier Nicolas, Franc Yannick, Bravo Francisco Damian, Ramon Charlotte, Øyås Ove, Juillerat Pascal, Macpherson Andrew J
Microbial network disturbances in relapsing refractory Crohn's disease
Yilmaz B, Stelling J, Wiest R, Swiss IBD Cohort Investigators, Rogler G, Maillard M, Pittet V, Geuking M, Mueller C, Michetti P, Fournier N, Franc Y, Bravo F, Ramon C, Øyås O, Juillerat P, Macpherson A. Microbial network disturbances in relapsing refractory Crohn's disease. Nat Med 2019; 25:323-336.
21.01.2019Microbial network disturbances in relapsing refractory Crohn's disease
21.01.2019Nat Med 2019; 25:323-336
Yilmaz Bahtiyar, Stelling Jörg, Wiest Reiner, Swiss IBD Cohort Investigators, Rogler Gerhard, Maillard Michel H, Pittet Valerie E H, Geuking Markus, Mueller Christoph, Michetti Pierre, Fournier Nicolas, Franc Yannick, Bravo Francisco Damian, Ramon Charlotte, Øyås Ove, Juillerat Pascal, Macpherson Andrew J
Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals
Pittet V, Maillard M, Simonson T, Fournier N, Rogler G, Michetti P, Swiss IBD Cohort Study Group(∗). Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals. Clin Gastroenterol Hepatol 2018; 17:2050-2059.e1.
22.11.2018Differences in Outcomes Reported by Patients With Inflammatory Bowel Diseases vs Their Health Care Professionals
22.11.2018Clin Gastroenterol Hepatol 2018; 17:2050-2059.e1
Pittet Valerie E H, Maillard Michel H, Simonson Thomas, Fournier Nicolas, Rogler Gerhard, Michetti Pierre, Swiss IBD Cohort Study Group(∗)